Redcare Pharmacy NV (XTER:RDC)
€ 135.9 -1.6 (-1.16%) Market Cap: 2.70 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 5.38 GF Score: 79/100

Q2 2023 Redcare Pharmacy NV Earnings Call Transcript

Aug 01, 2023 / 09:00AM GMT
Release Date Price: €116.05 (+9.90%)
Jasper Eenhorst
Redcare Pharmacy NV - CFO

Yeah, good morning, everybody. Welcome from Sevenum, the Netherlands. It's 11:00 local time here, and Monica Ambrosi and myself are very happy to be able to share with you today's numbers. We will present them and it will be followed by a Q&A session as always.

Today, August 1, is also the first official working day for Olaf Heinrich, the new CEO. And as of the coming quarter 3, Olaf and myself will host the presentation together. Today, very happy that Monica is again here just like past quarter.

So presenting from here, the agenda is straightforward. It's the same structure as always, starting with the financial performance of quarter two. And with that, of the first half of 2023, an update on business and strategy. And then, our outlook for the future financial performance and the Q3 -- sorry, the H1-2023 financial highlights.

Continued fast growth, and perhaps that's a little bit soft title because actually, our growth was 46% in quarter two. And with that, 34% over the first six months of this year compared to last year. If

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot